Healthcare provider profile · identity verified

Shravan Kumar Reddy Mallapu

Internal Medicine · BRONX, NY · NPI 1114182441

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	332	98
Eliquis	Apixaban	192	47
Amlodipine Besylate	Amlodipine Besylate	175	46
Gabapentin	Gabapentin	170	38
Levothyroxine Sodium	Levothyroxine Sodium	151	32
Tamsulosin Hcl	Tamsulosin Hcl	151	41
Hydralazine Hcl	Hydralazine Hcl	147	33
Losartan Potassium	Losartan Potassium	121	32
Mirtazapine	Mirtazapine	119	27
Carvedilol	Carvedilol	118	33
Metformin Hcl	Metformin Hcl	112	29
Januvia	Sitagliptin Phosphate	106	15
Jardiance	Empagliflozin	98	26
Sertraline Hcl	Sertraline Hcl	98	16
Metoprolol Succinate	Metoprolol Succinate	87	30
Famotidine	Famotidine	84	27
Lisinopril	Lisinopril	84	22
Latanoprost	Latanoprost	83	27
Finasteride	Finasteride	79	17
Furosemide	Furosemide	73	30
Pantoprazole Sodium	Pantoprazole Sodium	65	36
Torsemide	Torsemide	65	17
Memantine Hcl	Memantine Hcl	59	14
Nifedipine Er	Nifedipine	56	25
Allopurinol	Allopurinol	54	15
Clopidogrel	Clopidogrel Bisulfate	52	25
Levetiracetam	Levetiracetam	52	12
Risperidone	Risperidone	51	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Enulose	Lactulose	47	suppressed
Prednisone	Prednisone	45	12
Alogliptin	Alogliptin Benzoate	41	15
Warfarin Sodium	Warfarin Sodium	41	suppressed
Benztropine Mesylate	Benztropine Mesylate	38	suppressed
Entresto	Sacubitril/Valsartan	38	13
Trazodone Hcl	Trazodone Hcl	37	suppressed
Divalproex Sodium	Divalproex Sodium	36	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Sodium Chloride	0.9 % Sodium Chloride	35	15
Tradjenta	Linagliptin	35	suppressed
Clonidine	Clonidine	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	13
Spironolactone	Spironolactone	34	15
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	33	33
Enoxaparin Sodium	Enoxaparin Sodium	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	11
Metformin Hcl Er	Metformin Hcl	32	suppressed
Midodrine Hcl	Midodrine Hcl	31	11
Divalproex Sodium Er	Divalproex Sodium	30	suppressed
Baclofen	Baclofen	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Olanzapine	Olanzapine	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	12
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Potassium Chloride	Potassium Chloride	26	12
Xarelto	Rivaroxaban	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	25	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	11
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Voriconazole	Voriconazole	24	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	23	suppressed
Simvastatin	Simvastatin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	suppressed
Omeprazole	Omeprazole	20	12
Oxycodone Hcl	Oxycodone Hcl	20	11
Folic Acid	Folic Acid	19	suppressed
Lacosamide	Lacosamide	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Lactulose	Lactulose	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Amantadine	Amantadine Hcl	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	15	suppressed
Santyl	Collagenase Clostridium Hist.	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Prednisolone Acetate	Prednisolone Acetate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Darunavir	Darunavir	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	13	suppressed
Tivicay	Dolutegravir Sodium	13	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Vancomycin Hcl	Vancomycin Hcl	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error